Phase I trial of elacytarabine + idarubicin in patients with AML.
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2009
At a glance
- Drugs Elacytarabine (Primary) ; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 24 Apr 2009 New trial record.
- 22 Apr 2009 Results were presented at the 100th Annual Meeting of the American Association of Cancer Research (AACR) in Denver, Colorado.